Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Nanotoxicology|September 18, 2013
Co-assessment of cell cycle and micronucleus frequencies demonstrates the influence of serum on the in vitro genotoxic response to amorphous monodisperse silica nanoparticles of varying sizesLaetitia Gonzalez, Magdalena Lukamowicz-Rajska, Leen C J Thomassen, et al.Mutation Research. Genetic Toxicology and Environmental Mutagenesis|January 1, 2019
Analysis of historical negative control group data from the in vitro micronucleus assay using human lymphocytesDavid P Lovell, Mick Fellow, Azeddine Elhajouji, et al.Mutation Research|April 9, 2011
In vitro genotoxicity test approaches with better predictivity: summary of an IWGT workshopStefan Pfuhler, Mick Fellows, Jan van Benthem, et al.Environmental and Molecular Mutagenesis|March 1, 2013
Flow cytometric 96-well microplate-based in vitro micronucleus assay with human TK6 cells: protocol optimization and transferability assessmentSteven M Bryce, Svetlana L Avlasevich, Jeffrey C Bemis, et al.Mutation Research|September 22, 2009
Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshopStefan Pfuhler, David Kirkland, Peter Kasper, et al.Mutagenesis|March 8, 2026
Inclusion of a recovery period after pulse treatment in the primary human lymphocyte micronucleus assay covers potential cell cycle delays without loss of sensitivityAlina Goepfert, Miriam Spies, Natascha Partosa, et al.Mutation Research. Genetic Toxicology and Environmental Mutagenesis|January 9, 2018
Analysis of negative historical control group data from the in vitro micronucleus assay using TK6 cellsDavid P Lovell, Mick Fellows, Francesco Marchetti, et al.Mutation Research|January 10, 2008
Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assaySteven M Bryce, Svetlana L Avlasevich, Jeffrey C Bemis, et al.Journal of Medicinal Chemistry|July 3, 2023
Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS SyndromesSimone Bonazzi, Audrey Gray, Noel M Thomsen, et al.Chemmedchem|July 10, 2018
X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid SyndromeJoerg Kallen, Christian Bergsdorf, Bertrand Arnaud, et al.Pageof 5